Related Experiment Video
Updated: Jul 20, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
[Knowledge and implementation of cardiovascular risk clinical practice guidelines by general practitioners and
José R González-Juanatey1, Eduardo Alegría-Ezquerra, Joaquín Aznar-Costa
1Servicio de Cardiología, Hospital Clínico Universitario de Santiago, Santiago de Compostela, A Coruña, España.
Insights
Cardiovascular disease prevention targets are frequently missed in patients with type 2 diabetes or ischemic heart disease. Most risk factors, particularly oral antidiabetic use, were inadequately managed by physicians, indicating a significant gap in guideline adherence.
Area of Science:
- Cardiology
- Endocrinology
- Public Health
Context:
- High-risk cardiovascular disease patients often fail to meet clinical guidelines.
- The ACORISC registry assessed guideline compliance among general practitioners and specialists.
- Physician knowledge and adherence to preventive care standards were evaluated.
Purpose:
- To determine guideline compliance in cardiovascular disease prevention.
- To assess the management of risk factors in high-risk patients.
- To identify gaps in the application of clinical practice guidelines.
Summary:
- The study analyzed 5849 outpatients (mean age 65) with type 2 diabetes or chronic ischemic heart disease.
- Hypertension was present in 91% of patients; guideline-recommended angiotensin inhibitors were underused (48%).
- Treatment targets for blood pressure (13%), BMI (21%), and cholesterol (39%) were rarely met; 14% of treatments were inappropriate.
Impact:
- Significant gaps exist in the appropriate treatment of 75% of risk factors for patients with diabetes or ischemic heart disease.
- Inappropriate use of oral antidiabetics was a notable issue.
- Findings highlight the need for improved physician education and adherence to cardiovascular disease prevention guidelines.
Introduction And Objectives:
Patients at a high risk of cardiovascular disease rarely achieve the preventive targets stipulated by the clinical practice guidelines published by professional bodies. The aims of the ACORISC registry were to determine the level of compliance with guidelines on prevention by general practitioners and specialists and to assess the findings in terms of risk factors.
Methods:
The study included 5849 consecutive patients (mean age 65 years) with type 2 diabetes or chronic ischemic heart disease who were seen as outpatients. In addition, 384 participating physicians were questioned on their knowledge and use of practice guidelines.
Results:
Overall, 91% of patients also had hypertension. Physicians tended to have better knowledge of and to implement guidelines published by the closest related professional bodies. Some 14% of treatment provided was inappropriate, half of which involved oral antidiabetics. Conversely, 48% of patients for whom guidelines recommended an angiotensin inhibitor did not receive one. The target figures for blood pressure, body mass index, and cholesterol were achieved in only 13%, 21% and 39% of patients, respectively.
Conclusions:
Overall, 75% of risk factors in patients with diabetes or chronic ischemic heart disease were not appropriately treated by general practitioners or specialists in accordance with current clinical practice guidelines. The inappropriate use of oral antidiabetics was particularly common.
Related Concept Videos
Atherosclerosis III: Management
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Coronary Artery Disease IV: Preventive Measures
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Rheumatic Heart Disease III: Medical Management
